Skip to main content
. 2024 Mar 13;15:2254. doi: 10.1038/s41467-024-46490-7

Fig. 4. Replication of SARS-CoV-2 variants in hNECs.

Fig. 4

Primary human nasal epithelial cells (hNECs) cultivated at the air–liquid interface (ALI) were exposed to the indicated SARS-CoV-2 variants. a Viral RNA release from the apical side of hNECs was measured by RT-qPCR every day up to 4 days p.i. Replication kinetics of each variant from one representative experiment are represented. b Comparison of viral RNA release at day 1 pi with the indicated variants. c Infectious viral titers in supernatants from the apical side were quantified with S-Fuse cells at day 2 p.i. b,c. Data are mean ± s.d. of 4 (D614G, Delta), 5 (BA.1, BQ1.1, XBB.1, EG.5.1.3, BA.2.86.1) or 6 (BA.5, XBB.1.5) independent experiments. One-way ANOVA with Kruskal-Wallis test followed by Dunn’s test for multiple comparisons to compare Delta with respective variants were conducted. c D614G vs. BQ.1.1, p-value = 0.0032; D614G vs. XBB.1, p-value = 0.0116; D614G vs. EG.5.1.3, p-value = 0.0057. d Immunofluorescence of hNECs stained for tubulin (cyan), actin (yellow), SARS-CoV-2 Nucleocapsid (green) and cleaved caspase-3 (red). Shown is one representative field (150 × 150 mm) of each variant. Images are from one representative experiment out of 2. Scale bar = 20 μm. Source data are provided as a Source Data file.